[{"evidenceId":18143,"evidenceType":"GENE_SUMMARY","shortDesc":null,"desc":"RFWD2 (Ring Finger And WD Repeat Domain 2), also known as COP1, encodes a E3 ubiquitin-protein ligase involved in the c-Jun signaling pathway that affects apoptosis, cell cycle, and DNA repair. RFWD2 is a tumor suppressor and is commonly overexpressed in several cancer types, including gastric, human hepatocellular carcinoma, breast, and ovarian cancer and promotes cell proliferation, transformation, and tumor progression.","id":null,"lastEdit":"2017-01-18","status":null,"gene":{"entrezGeneId":64326,"hugoSymbol":"RFWD2","name":"ring finger and WD repeat domain 2","oncogene":false,"curatedIsoform":"ENST00000367669","curatedRefSeq":"NM_022457.5","geneAliases":["RNF200","COP1"],"tsg":false},"articles":[]},{"evidenceId":18144,"evidenceType":"GENE_BACKGROUND","shortDesc":null,"desc":"RFWD2 (Ring Finger And WD Repeat Domain 2), also known as COP1 (constitutive photomorphogenic 1), encodes a E3 ubiquitin-protein ligase that contains a RING-finger, coiled-coil, and WD40-repeat domains and negatively regulates the oncoprotein c-Jun and tumor suppressor protein, p53. (PMID: 12615916, 21403399, 20333547). RFWD2 is a tumor suppressor that plays an important role in cell proliferation, transformation, and tumor progression. (PMID: 21135113) RFWD2 is overexpressed in tumors and mediates p53 degradation and function. (PMID: 20333547) RFWD2 is commonly overexpressed in several tumor types, including gastric, hepatocellular carcinoma, breast, and ovarian adenocarcinomas, and are associated with poor overall survival (PMID: 23091414,15492238, 20953491)","id":null,"lastEdit":"2017-01-18","status":null,"gene":{"entrezGeneId":64326,"hugoSymbol":"RFWD2","name":"ring finger and WD repeat domain 2","oncogene":false,"curatedIsoform":"ENST00000367669","curatedRefSeq":"NM_022457.5","geneAliases":["RNF200","COP1"],"tsg":false},"articles":[{"pmid":"21403399","title":"Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.","journal":"The Journal of clinical investigation","pubDate":"2011 Apr","volume":"121","issue":"4","pages":"1329-43","authors":"Migliorini D et al","elocationId":"doi: 10.1172/JCI45784","link":null,"reference":"Migliorini D et al. The Journal of clinical investigation. 2011 Apr;121(4)1329-43.","abstract":null},{"pmid":"20953491","title":"Synthesis of substituted 8-aminoquinolines and phenanthrolines through a Povarov approach.","journal":"Organic &amp; biomolecular chemistry","pubDate":"2011 Jan 21","volume":"9","issue":"2","pages":"347-50","authors":"De K et al","elocationId":"doi: 10.1039/c0ob00496k","link":null,"reference":"De K et al. Organic &amp; biomolecular chemistry. 2011 Jan 21;9(2)347-50.","abstract":null},{"pmid":"21135113","title":"14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.","journal":"Cancer research","pubDate":"2011 Feb 1","volume":"71","issue":"3","pages":"884-94","authors":"Su CH et al","elocationId":"doi: 10.1158/0008-5472.CAN-10-2518","link":null,"reference":"Su CH et al. Cancer research. 2011 Feb 1;71(3)884-94.","abstract":null},{"pmid":"12615916","title":"Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity.","journal":"The Journal of biological chemistry","pubDate":"2003 May 30","volume":"278","issue":"22","pages":"19682-90","authors":"Bianchi E et al","elocationId":"","link":null,"reference":"Bianchi E et al. The Journal of biological chemistry. 2003 May 30;278(22)19682-90.","abstract":null},{"pmid":"15492238","title":"COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.","journal":"Cancer research","pubDate":"2004 Oct 15","volume":"64","issue":"20","pages":"7226-30","authors":"Dornan D et al","elocationId":"","link":null,"reference":"Dornan D et al. Cancer research. 2004 Oct 15;64(20)7226-30.","abstract":null},{"pmid":"20333547","title":"Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.","journal":"Molecular biology reports","pubDate":"2011 Jan","volume":"38","issue":"1","pages":"229-36","authors":"Wang L et al","elocationId":"doi: 10.1007/s11033-010-0099-x","link":null,"reference":"Wang L et al. Molecular biology reports. 2011 Jan;38(1)229-36.","abstract":null},{"pmid":"23091414","title":"High level of COP1 expression is associated with poor prognosis in primary gastric cancer.","journal":"International journal of biological sciences","pubDate":"2012","volume":"8","issue":"8","pages":"1168-77","authors":"Li YF et al","elocationId":"doi: 10.7150/ijbs.4778","link":null,"reference":"Li YF et al. International journal of biological sciences. 2012;8(8)1168-77.","abstract":null}]}]